Study Shows Changes in Dopamine Markers in Canadians with Long COVID

A recent study focused on 24 individuals in Canada diagnosed with long COVID has revealed notable changes in dopamine markers. This research suggests that these changes may point to possible injury to dopamine neurons, which play a crucial role in regulating mood and movement. Furthermore, the findings highlight a connection between COVID-related fatigue and reduced blood flow to the brain, underscoring the complexity of long COVID symptoms. Researchers are continuing to explore these connections to better understand the long-term health impacts of the virus and develop potential therapeutic strategies.